Form D — HAWKHILL THERAPEUTICS Ltd
0002140690-26-000001 · filed Jun 23, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $192,569
- Reported amount sold
- $192,569
- Minimum investment
- $0
- Investors
- 1
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- HAWKHILL THERAPEUTICS Ltd
- CIK
- 2140690
- Entity
- Limited Liability Company
- Jurisdiction
- UNITED KINGDOM
- Year incorporated
- 2025
- Address
- LIFE SCIENCES INNOVATION HUB
DUNDEE, SCOTLAND, X0 DD1 5JJ - Phone
- 5555555555
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Christopher Andrew Woodland · Executive OfficerDundee, Scotland, X0 Find on LinkedIn ↗
-
Antoine Boulanger · Executive OfficerDundee, Scotland, X0 Find on LinkedIn ↗
-
Mary Canning · Executive OfficerDundee, Scotland, X0 Find on LinkedIn ↗
-
Francisca Peixoto · Executive OfficerDundee, Scotland, X0 Find on LinkedIn ↗
-
Timothy Jason Sparey · Executive OfficerDundee, Scotland, X0 Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗